Persistent organic pollutants in infants and toddlers: Relationship between concentrations in matched plasma and

Yiqin Chen1, Andreas Sjodin2, Michael S McLachlan3

  • 1Queensland Alliance for Environmental Health Sciences, The University of Queensland, Australia.

Insights

Faeces offer a promising, non-invasive method for biomonitoring persistent organic pollutants (POPs) in infants. Fecal POP concentrations correlate well with blood levels, aiding exposure assessment in early childhood.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatric Research

Background:

  • Early-childhood biomonitoring of persistent organic pollutants (POPs) is hindered by invasive blood sampling.
  • Non-invasive matrices are needed to assess internal POP exposure in infants and toddlers.
  • Faeces present a potential alternative matrix for POP biomonitoring.

Purpose of the Study:

  • To investigate the utility of faeces as a non-invasive matrix for estimating internal POP exposure in young children.
  • To compare POP concentrations in matched plasma and faecal samples.
  • To establish faeces:plasma concentration ratios (Kfb) for estimating blood POP levels.

Main Methods:

  • Collected matched plasma and faecal samples from 20 infants/toddlers (aged 13±4.8 months).
  • Measured concentrations of selected POPs in both matrices, including repeat sampling for 13 participants.
  • Analyzed quantification frequencies and correlations between fecal (Cf) and blood (Cb) POP concentrations.

Main Results:

  • Higher POP quantification rates were observed in faeces compared to plasma.
  • Significant correlations (r>0.74, P<0.05) were found between fecal and blood concentrations for several POPs (p,p'-DDE, PCB118, PCB138, PCB153).
  • Faeces:plasma concentration ratios (Kfb) were determined, though considerable individual variation was noted, partly due to short-term intra-individual variability.

Conclusions:

  • Faecal biomonitoring is a promising non-invasive method for assessing POP exposure in infants and toddlers.
  • Strong correlations between fecal and blood POP levels support the use of faeces for exposure estimation.
  • Further research into the sources of Kfb variability is needed to enhance the precision and utility of this technique.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377